Sign inJoin waitlistJoin the waitlist

Andres Correa

Urologic Oncology Fellowship Director · Temple University Hospital

Credentials: · · · ·

History

Urologic Oncology Fellowship · Temple University Hospital
Present
SUO Urologic Oncology Fellowship · Temple University Hospital
Present
Department of Urology · Temple University Hospital
Present

Fox Chase Cancer Center
2015–2016
Urology
UPMC
2011–2012
UPMC
2010–2011
University of Maryland School of Medicine
2006–2010

Research

Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation
Journal of Clinical Oncology · 2019 · First of 14 authors · 112 citations
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
European Urology · 2021 · First of 15 authors · Corresponding · 63 citations
Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis
JAMA Oncology · 2018 · 58 citations

Robert Uzzo
38 papers
Alexander Kutikov
30 papers
Marc Smaldone
26 papers · 5 as a fellow
Laura Bukavina
18 papers · 17 as a fellow
David Chen
17 papers
Ithaar Derweesh
15 papers
Rosalia Viterbo
15 papers
RG
Richard Greenberg
13 papers
Chandru Sundaram
12 papers
Firas Abdollah
12 papers
Hooman Djaladat
12 papers · 9 as a fellow
Mark Gonzalgo
12 papers

Clinical trials

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2028
Genomic Risk in Retroperitoneal Sarcoma
Sub-investigator · Recruiting
Fox Chase Cancer Center
2022–2027